| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $633M | — | — | — | — |
| Op. Income | $165M | — | — | — | — |
| Gross Margin | 61.1% | — | — | — | — |
| Net Margin | 20.7% | — | — | — | — |
| EPS (Diluted) | $1.18 | — | — | — | — |
| Free Cash Flow | -$26M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $633M |
| Cost of Revenue | $247M |
| GROSS PROFIT | $387M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $180M |
| SG&A Expenses | $180M |
| Other Expenses | $42M |
| Operating Expenses | $222M |
| Cost & Expenses | $469M |
| OPERATING INCOME | $165M |
| Interest Income | $495M |
| Interest Expense | $173M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $165M |
| Income Tax Expense | $34M |
| Net Income from Continuing Ops | $131M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $2M |
| NET INCOME | $131M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $131M |
| D&A | $37M |
| EBIT | $165M |
| EBITDA | $202M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $633M |
| Cost of Revenue | $247M |
| GROSS PROFIT | $387M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $180M |
| SG&A Expenses | $180M |
| Other Expenses | $42M |
| Operating Expenses | $222M |
| Cost & Expenses | $469M |
| OPERATING INCOME | $165M |
| Interest Income | $495M |
| Interest Expense | $173M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $165M |
| Income Tax Expense | $34M |
| Net Income from Continuing Ops | $131M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $2M |
| NET INCOME | $131M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $131M |
| D&A | $37M |
| EBIT | $165M |
| EBITDA | $202M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $131M |
| Depreciation & Amortization | $37M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $115M |
| Change in Working Capital | -$303M |
| OPERATING CASH FLOW | -$19M |
| Capital Expenditure | -$7M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $171M |
| NET CASH FROM INVESTING | $164M |
| Net Debt Issuance | $54M |
| Common Stock Repurchased | -$8M |
| Common Dividends Paid | -$4M |
| Other Financing Activities | -$397M |
| NET CASH FROM FINANCING | -$355M |
| FREE CASH FLOW | -$26M |
| Net Change in Cash | -$209M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $3.3B |
| Short-Term Investments | $6.3B |
| Net Receivables | $1.5B |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $11.2B |
| PP&E (Net) | $249M |
| Goodwill | $0 |
| Intangible Assets | $466M |
| Long-Term Investments | $15.3B |
| Tax Assets | $10M |
| Other Non-Current Assets | $855M |
| TOTAL NON-CURRENT ASSETS | $16.9B |
| TOTAL ASSETS | $28.1B |
| Account Payables | $177M |
| Short-Term Debt | $694M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $15.3B |
| TOTAL CURRENT LIABILITIES | $16.2B |
| Long-Term Debt | $2.7B |
| Deferred Revenue NC | $562M |
| Deferred Tax Liabilities | $36M |
| Other Non-Current Liabilities | $5.1B |
| TOTAL NON-CURRENT LIABILITIES | $8.5B |
| TOTAL LIABILITIES | $24.7B |
| Common Stock | $301M |
| Additional Paid-In Capital | $154M |
| Retained Earnings | $499M |
| Treasury Stock | -$125M |
| Accum. Other Comp. Income | $2.6B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $3.4B |
| Minority Interest | $20M |
| TOTAL EQUITY | $3.5B |
| TOTAL LIABILITIES & EQUITY | $28.1B |
| Total Debt | $3.5B |
| Net Debt | $120M |
